Pentravan | 2022 Ex-vivo study of the percutaneous absorption of a tramadol formulation through feline inner pinna skin Sainte Beuve M, Espana B, Pin D, Prouillac C Research in Veterinary Science, 151, 57-63. This ex vivo study aimed to characterize the percutaneous absorption pharmacokinetics of tramadol 100mg/ml in Pentravan through feline inner pinna skin. The tramadol formulation was stable for three months at room temperature. Tramadol penetrated through the feline inner pinna skin, but considerable intra- and inter-individual variability in kinetics was observed. Read article
TrichoConcept | 2022 Compatibility of different formulations in TrichoConcept vehicles for hair treatments Polonini HC, Taylor S, Zander C Scientia Pharmaceutica, 90(1), 16. This study assessed the beyond-use date (BUD) of seven APIs for topical use for alopecia in TrichoWash, TrichoCream, TrichoCond, and TrichoSol: All formulations presented a BUD of 6 months, except for latanoprost in TrichoCream and latanoprost in combination with minoxidil and finasteride in TrichoSol (BUD 3 months). Read article
Fagron Advanced Derma | 2021 Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Polonini HC, Dijkers E, Ferreira AO, Zander C, Taylor S International Journal of Pharmaceutical Compounding, 25(4), 336-343. In this study, the beyond-use date of formulations containing estradiol, estriol, estrone, progesterone, and testosterone in combination, compounded with Fitalite, Versatile, and HRT Supreme Cream base was evaluated. A beyond-use date of 180 days was observed for all vehicles stored both at refrigerated and at room temperature. Read article
Yuliv Collagen Drink | 2021 Beauty from within: A Review of the Science behind YulivTM Collagen Drink: An Anti-Aging Nutraceutical Polonini HC, Dijkers E, Ferreira AO Journal of Cosmetics, Dermatological Sciences and Applications, 11(3), 263-278. In this article, theoretical scientific support for Yuliv Collagen Drink and its benefits on the skin is presented. Literature shows that its ingredients have the potential to improve hydration, and dermis collagen density. Other benefits observed include oxidative stress protection, immune system support, and reduction of fatigue, and skin inflammation. Read article
FagronLab | 2021 Ensuring Homogeneity in Powder Mixtures for Pharmaceuticals and Dietary Supplements: Evaluation of a 3-Axis Mixing Equipment Marianni B, Polonini HC, Oliveira MAL Pharmaceutics, 3(4), 563-572. The study evaluated the efficacy of a new 3-axis mixer device. Three formulations were compounded, a total of 540 individual tests were performed, and two alternative methods were compared. The 3-axis device provided homogeneous mixtures and finished capsules with adequate content uniformity, and proved superior to classical mixing methods. Read article
ImunoTF | 2021 Characterization and safety profile of Imuno TF®, a nutritional supplement for immune system regulation containing transfer factors Polonini HC, de Souza Schmidt Gonçalves AE, Dijkers E, Ferreira AO Biomolecules, 11(5), 665-676. This study demonstrates the proteomic analysis, nutritional composition, and safety profile of Imuno TF®, a complex set of 163 different peptides, 10 vitamins, and 11 minerals. The chemical composition showed low fat and sugar content and no saturated fatty acids. No mutagenic effect was observed. Read article
Cleoderm | 2021 Cleoderm™ Clarifying Cream: A Novel, Topical Vehicle Using Plant-Based Excipients and Actives Targeting Acne and Oily Skin Polonini HC, Zander C, Radke J Journal of Cosmetics, Dermatological Sciences and Applications, 11(4), 422-426. In this paper, Cleoderm is presented as a ready-to-use vehicle for the compounding of acne treatments and products for oily skin. Evidence shows multiple positive roles of Cleoderm including a decrease in sebum production, lipid peroxidation, and reactive oxygen species, inhibition of Cutibacterium acnes proliferation, and control of inflammation. Read article
Pentravan | 2021 Assessment of the Effect of Structural Modification of Ibuprofen on the Penetration of Ibuprofen from Pentravan® (Semisolid) Formulation Using Human Skin and a Transdermal Diffusion Test Model Ossowicz-Rupniewska P, Nowak A, Klebeko J, Janus E, Duchnik W, Adamiak-Giera U, Kucharski L, Prowans P, Petriczko J, Czapla N, Bargiel P, Markowska M, Klimowicz A Materials, 14(22), 6808-6826. The effect of Pentravan® on skin permeability was examined for unmodified ibuprofen (IBU) and ion pairs of ibuprofen with new L-valine alkyl esters. The resulting Pentravan-based creams with ibuprofen in the form of an ionic pair represent a potential alternative to other forms of the drug-containing analgesics administered transdermally. Read article
Pentravan | 2021 Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan® for Transdermal and Transmucosal Application Polonini HC, Ferreira AO, Dijkers E International Journal of Pharmaceutical Compounding, 25(5), 422-426. In this work, the compatibility of Pentravan and three active pharmaceutical ingredients was determined: gestrinone, a steroidal substance for vaginal use, and nimesulide and piroxicam, two nonsteroidal anti-inflammatory drugs used for topical and vaginal application. This article shows an excellent beyond-use date of 180 days when stored at room temperature. Read article
Pentravan | 2021 Compatibility of Different Formulations in Pentravan® and Pentravan® Plus for Transdermal Drug Delivery Polonini HC, Taylor S, Zander C Scientia Pharmaceutica, 89(4), 51. In this study, the stability in Pentravan®/Plus of danazol, metformin HCl, and resveratrol, as well as metformin HCl, resveratrol, and Vitamin D3 in combinations at bracketed high/low concentrations, were evaluated over a period of 6 months. All formulations presented a beyond-use date of at least 6 months. Read article